Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This is a single-arm, open-label study to examine the effect of dupilumab on the immunologic
and genetic environment within atopic dermatitis skin lesions.